- Clinical validation of improved mental health through Sinasprite via peer-reviewed publications
- Strategic investors include Bayer Pharmaceuticals, SinofinaRx, NexCubed, and Jumpstart Foundry.
- Affinity with difficult to motivate populations including Medicaid patients: "I use it daily lately because I cannot calm myself down.” – F, 48, Bipolar & Depression.
- Consistently recognized as a high-potential sustainable healthcare business: top 1.5% of the Bayer Pharmaceuticals applicant pool and top 0.3% of the NexCubed applicant pool
- Robust organic growth during COVID-19: A 50% increase in sign-ups since March 10th
- Minimal sales optimization: revenue realised, robust sales pipeline & increased inbound requests from pharma, payers & providers